E Fund Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$591K Sell
5,744
-6,356
-53% -$414K 0.01% 236
2026
Q1
$575K Buy
+12,100
New +$543K 0.02% 263
2025
Q2
$311K Sell
8,445
-834
-9% -$28.8K 0.01% 297
2025
Q1
$364K Buy
9,279
+2,646
+40% +$119K 0.02% 265
2024
Q4
$308K Sell
6,633
-2,305
-26% -$104K 0.02% 308
2024
Q3
$404K Buy
8,938
+2,677
+43% +$127K 0.02% 220
2024
Q2
$309K Sell
6,261
-5,274
-46% -$215K 0.02% 227
2024
Q1
$396K Sell
11,535
-748
-6% -$27K 0.02% 224
2023
Q4
$453K Sell
12,283
-5,127
-29% -$119K 0.03% 180
2023
Q3
$353K Sell
17,410
-4,836
-22% -$106K 0.03% 189
2023
Q2
$455K Sell
22,246
-2,228
-9% -$33.4K 0.04% 126
2023
Q1
$369K Buy
24,474
+7,243
+42% +$160K 0.03% 195
2022
Q4
$410K Buy
17,231
+6,414
+59% +$186K 0.03% 176
2022
Q3
$381K Sell
10,817
-5,534
-34% -$235K 0.04% 193
2022
Q2
$572K Buy
16,351
+10,225
+167% +$362K 0.05% 122
2022
Q1
$303K Buy
+6,126
New +$340K 0.01% 191

Other funds holding TWST

E Fund Management's TWST Position: Q2 2026 in Review

E Fund Management reduced its Twist Bioscience (TWST) stake by 53% in Q2 2026, selling an estimated $414K and leaving 5,744 shares worth $591K. The position accounts for 0.01% of the portfolio, ranked #236.

E Fund Management first reported a position in TWST in Q1 2022 and has held it in 16 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • E Fund Management held 5,744 shares of Twist Bioscience worth $591K as of Q2 2026.
  • E Fund Management sold 6,356 Twist Bioscience shares in Q2 2026, an estimated $414K.
  • Twist Bioscience made up 0.01% of E Fund Management's portfolio in Q2 2026, its #236 holding.
  • E Fund Management first reported a position in Twist Bioscience in Q1 2022 and has held it in 16 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.